Clinical Trial

Lighthouse Parenting Nanai: a Mentalization-based Group Therapy for Caregivers with History of Trauma

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 21, 2025 (before its estimated May 5, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this feasibility randomized controlled trial is to evaluate the effectiveness and acceptability of the Lighthouse Mentalization-Based Treatment Parenting Program (Lighthouse MBT-P) as an intervention for parents at risk of maltreating their children. The study focuses on parents with a history of childhood trauma, aiming to improve parent-child relationships, reduce parenting stress, and ultimately decrease the risk of child maltreatment. The goal of this study is to test how well the Lighthouse Mentalization-Based Treatment Parenting Program (Lighthouse MBT-P) works for parents who may be at risk of harming their children. The program aims to help parents understand and manage their own and their children's emotions better. By improving these skills, the program hopes to reduce stress in parenting and lower the chances of child abuse or neglect. The main questions this study will answer are: * Can parents follow and complete the Lighthouse MBT-P program? * Does the program help lower stress in parenting and improve relationships between parents and their children? Participants in this study will: * Attend weekly group sessions for 12 weeks. These sessions will teach them how to better understand and manage emotions. * Take part in discussions led by trained psychologists. Researchers will compare the results of parents who take part in the Lighthouse MBT-P program with those who receive standard parenting support to see which approach works better.
Trial Details
NCT Number NCT06889519
Lead Sponsor University Diego Portales
Conditions Child Maltreatment, Trauma, Psychological
Enrollment 60 participants
Start Date 2024-08-17
Primary Completion 2025-05-05 (estimated)
Study Completion 2025-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-21